IRIS
CANNAVO', Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.644
NA - Nord America 12.321
AS - Asia 7.212
SA - Sud America 2.579
Continente sconosciuto - Info sul continente non disponibili 791
AF - Africa 197
OC - Oceania 14
Totale 36.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.052
RU - Federazione Russa 7.004
SG - Singapore 3.037
BR - Brasile 2.202
CN - Cina 2.037
IE - Irlanda 1.517
SE - Svezia 1.204
IT - Italia 1.057
HK - Hong Kong 809
DE - Germania 603
FR - Francia 470
VN - Vietnam 437
UA - Ucraina 428
PL - Polonia 406
GB - Regno Unito 350
FI - Finlandia 289
IN - India 172
AR - Argentina 132
BD - Bangladesh 113
CA - Canada 105
MX - Messico 93
TR - Turchia 74
IQ - Iraq 70
EC - Ecuador 64
ID - Indonesia 63
JP - Giappone 57
AT - Austria 51
NL - Olanda 51
PK - Pakistan 51
UZ - Uzbekistan 51
ZA - Sudafrica 48
CO - Colombia 44
BE - Belgio 43
VE - Venezuela 42
ES - Italia 40
MA - Marocco 40
CL - Cile 26
CZ - Repubblica Ceca 26
MY - Malesia 24
AE - Emirati Arabi Uniti 23
KE - Kenya 23
PE - Perù 23
TN - Tunisia 22
PH - Filippine 20
SA - Arabia Saudita 20
PY - Paraguay 18
JO - Giordania 16
CI - Costa d'Avorio 15
NP - Nepal 15
CR - Costa Rica 14
IL - Israele 13
JM - Giamaica 13
KG - Kirghizistan 13
UY - Uruguay 13
AZ - Azerbaigian 12
DZ - Algeria 12
LT - Lituania 12
OM - Oman 12
AL - Albania 11
BO - Bolivia 11
AU - Australia 10
KZ - Kazakistan 10
SN - Senegal 9
GR - Grecia 8
MD - Moldavia 8
EE - Estonia 7
HU - Ungheria 7
LK - Sri Lanka 7
NI - Nicaragua 7
DO - Repubblica Dominicana 6
EG - Egitto 6
GT - Guatemala 6
PA - Panama 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
HN - Honduras 5
LB - Libano 5
LV - Lettonia 5
NO - Norvegia 5
QA - Qatar 5
RS - Serbia 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
HR - Croazia 4
KH - Cambogia 4
KW - Kuwait 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
CY - Cipro 3
ET - Etiopia 3
Totale 35.925
Salva come PNG Salva come JPEG
Città #
Moscow 2.085
Ashburn 2.004
Singapore 1.671
Dublin 1.515
Chandler 1.236
Dallas 1.083
Jacksonville 915
Hong Kong 804
Nyköping 695
Beijing 651
San Jose 629
Warsaw 388
Messina 366
The Dalles 366
Princeton 290
Los Angeles 278
Dearborn 274
Lauterbourg 259
Medford 234
Cambridge 228
Des Moines 207
Munich 175
New York 172
São Paulo 170
Buffalo 156
Ann Arbor 136
Boardman 134
Ho Chi Minh City 122
Council Bluffs 119
Lancaster 111
Santa Clara 111
Tianjin 109
Wilmington 89
Hanoi 86
Shenyang 72
Rio de Janeiro 71
Belo Horizonte 68
Redondo Beach 66
Jinan 63
Frankfurt am Main 62
San Mateo 60
Nanjing 59
Orem 59
Guangzhou 57
Dong Ket 56
Rome 56
Brooklyn 52
Seattle 50
Tashkent 48
Hyderabad 46
Helsinki 45
Tokyo 45
Houston 44
Woodbridge 43
Brussels 40
Haikou 39
Shanghai 39
Atlanta 37
Nuremberg 37
Jakarta 36
London 36
Catania 35
Curitiba 35
Denver 35
Hebei 35
Turku 33
Zhengzhou 32
Brasília 31
Hangzhou 31
Porto Alegre 31
Vienna 31
Bremen 30
Mexico City 30
Shenzhen 30
Nanchang 29
Manchester 28
Chennai 27
Chicago 27
Johannesburg 27
Milan 27
Montreal 27
Baghdad 26
Stockholm 26
Amsterdam 25
Ningbo 25
Turin 23
Campinas 22
Pune 22
Toronto 22
San Francisco 21
Fortaleza 20
Nairobi 20
Quito 20
Ribeirão Preto 20
Salvador 20
Ankara 19
Bogotá 19
Düsseldorf 19
Poplar 19
Falls Church 18
Totale 20.271
Salva come PNG Salva come JPEG
Nome #
Aggressive pituitary adenomas: the dark side of the moon 273
La chirurgia tiroidea transorale 268
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 252
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 242
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 227
Acne ed irsutismo: patologie endocrine? 214
Effects of cyberknife radiotherapy treatment of pituitary adenomas 213
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 212
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 210
A 53-year-old woman with Cushing's disease and a pituitary tumor 209
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 207
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 205
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 203
A case of clinically silent acromegaly with erectile dysfunction. 197
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 197
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 196
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 193
Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella 192
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 192
L’apoplessia ipofisaria: riconoscerla rapidamente e trattarla correttamente. 192
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 182
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 182
Global epidemiology of acromegaly: A systematic review and meta-analysis 182
Acromegaly is associated with increased cancer risk: a survey in Italy 181
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 181
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 180
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 180
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 178
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 177
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 177
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 177
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 177
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 176
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 176
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR)in a patient with glucocorticoid resistance 175
Increased prevalence of acromegaly in a highly polluted area. 174
Analisi dell'intervallo QT all'ECG di superficie in pazienti affetti da deficit primario di GH con e senza ipertrofia ventricolare sinistra 174
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 171
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 170
Oxidative stress as a key feature of autoimmune thyroiditis: an update 170
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 169
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 169
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 169
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 168
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 167
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 166
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 165
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 165
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 165
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 165
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 163
Course of pregnancies in women with Cushing's disease treated by gamma-knife 163
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 163
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 160
Atrial parasystole in left ventricular noncompaction: a morphofunctional study by echocardiography and magnetic resonance imaging. 160
Predictive markers of recurrence in radically resected pituitary macroadenomas 159
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 157
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 157
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 157
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 156
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 155
Multidisciplinary management of pituitary apoplexy 154
Adrenal Cushing Syndrome: Diagnosis and Management in a 10-Year-Old Boy with Carney Complex 153
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR) in a patient with glucocorticoid resistance. 153
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 152
Modificazione del pattern secretivo, dopo chirurgia, e dei marker proliferativi cellulari, dopo radioterapia (gamma-knife), in un corticotropinoma invasivo. 151
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 151
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 151
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 150
Oral mucositis induced by treatment with soft gel formulation of levothyroxine 149
Commentary on "Co-Occurrence of Pituitary Adenoma With Suprasellar and Olfactory Groove Meningiomas" 149
Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography 147
N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders 147
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 147
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 147
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 147
Thyroid nodules in growth hormone replaced patients. 145
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 144
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 144
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 144
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 143
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 142
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 141
How to improve effectiveness of pegvisomant treatment in acromegalic patients 141
An unusual case of idiopathic hyperprolactinemia 140
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 139
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 139
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 139
Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations. 138
Temozolomide-induced shrinkage of a pituitary carcinoma. 137
Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description 137
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 136
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 135
Spontaneous intermittent MRI changes of a pituitary stalk lesion causing diabetes insipidus and amenorrhea 135
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 134
Modificazione dei parametri di rischio cardiovascolare durante trattamento sostitutivo prolungato con ormone della crescita 134
Subcutaneous lipoatrophy induced by long-term pegvisomant administration 133
DISSOCIATION BETWEEN IN VIVO (OCTREOSCAN) AND IN VITRO EXPRESSION OF SPECIFIC SOMATOSTATIN RECEPETORS AND RESPONSIVENESS TO SOMATOSTATIN ANALOGS (SSAs) TREATMENT IN A FSH-SECRETING PITIUTARY ADENOMA 133
Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto's thyroiditis. 133
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 132
Totale 16.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.684 0 219 31 95 50 23 85 75 41 205 243 617
2022/20234.670 394 357 202 384 323 477 88 295 1.847 47 197 59
2023/20241.199 111 213 98 108 111 212 20 104 4 65 7 146
2024/20256.031 101 83 162 316 337 139 171 1.308 1.563 382 473 996
2025/202617.128 773 1.038 1.298 1.050 1.482 3.708 2.167 2.021 2.080 779 347 385
2026/2027717 542 175 0 0 0 0 0 0 0 0 0 0
Totale 36.758